n-3 polyunsaturated fatty acids (PUFAs) or vitamin E, or both, v no supplement after recent myocardial infarction (MI)‡
Outcomes at 42 months | Supplement type | Supplement | No Supplement | RRR (95% CI) | NNT (CI) |
---|---|---|---|---|---|
‡Abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article. MI and stroke refer to non-fatal events. | |||||
Death, MI, and stroke | n-3 PUFAs | 12.6% | 14.6% | 14% (2 to 25) | 48 (26 to 332) |
Vitamin E | 13.1% | 14.6% | 10% (−2 to 21) | Not significant | |
Combined | 12.7% | 14.6% | 13% (1 to 24) | 52 (27 to 610) | |
Cardiovascular death, MI, and stroke | n-3 PUFAs | 9.2% | 11.4% | 19% (5 to 30) | 47 (27 to 177) |
Vitamin E | 10.1% | 11.4% | 11% (−3 to 24) | Not significant | |
Combined | 10.1% | 11.4% | 12% (−3 to 24) | Not significant |